FR2531433B1 - Nouveaux alcaloides de l'ergot de seigle, leur preparation et leur utilisation comme medicaments - Google Patents

Nouveaux alcaloides de l'ergot de seigle, leur preparation et leur utilisation comme medicaments

Info

Publication number
FR2531433B1
FR2531433B1 FR8313018A FR8313018A FR2531433B1 FR 2531433 B1 FR2531433 B1 FR 2531433B1 FR 8313018 A FR8313018 A FR 8313018A FR 8313018 A FR8313018 A FR 8313018A FR 2531433 B1 FR2531433 B1 FR 2531433B1
Authority
FR
France
Prior art keywords
medicaments
preparation
ergot alkaloids
novel
rye ergot
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8313018A
Other languages
English (en)
French (fr)
Other versions
FR2531433A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2531433A1 publication Critical patent/FR2531433A1/fr
Application granted granted Critical
Publication of FR2531433B1 publication Critical patent/FR2531433B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
FR8313018A 1982-08-09 1983-08-04 Nouveaux alcaloides de l'ergot de seigle, leur preparation et leur utilisation comme medicaments Expired FR2531433B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH4772/82A CH649998A5 (de) 1982-08-09 1982-08-09 Ergolinderivate, ein verfahren zu ihrer herstellung und heilmittel, enthaltend diese ergolinderivate als wirkstoff.

Publications (2)

Publication Number Publication Date
FR2531433A1 FR2531433A1 (fr) 1984-02-10
FR2531433B1 true FR2531433B1 (fr) 1985-10-18

Family

ID=4282273

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8313018A Expired FR2531433B1 (fr) 1982-08-09 1983-08-04 Nouveaux alcaloides de l'ergot de seigle, leur preparation et leur utilisation comme medicaments

Country Status (23)

Country Link
JP (1) JPS5948480A (da)
AT (1) AT383125B (da)
AU (1) AU563736B2 (da)
BE (1) BE897473A (da)
CA (1) CA1215972A (da)
CH (1) CH649998A5 (da)
DE (1) DE3327705A1 (da)
DK (1) DK361983A (da)
ES (1) ES8502992A1 (da)
FI (1) FI73679C (da)
FR (1) FR2531433B1 (da)
GB (1) GB2125041B (da)
GR (1) GR78923B (da)
HU (1) HU187600B (da)
IL (1) IL69450A (da)
IT (1) IT1168961B (da)
MY (1) MY8700166A (da)
NL (1) NL8302776A (da)
NZ (1) NZ205181A (da)
PH (1) PH20385A (da)
PT (1) PT77168B (da)
SE (1) SE8304315L (da)
ZA (1) ZA835850B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
HU193782B (en) * 1985-06-21 1987-11-30 Richter Gedeon Vegyeszet Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof
FR2589734B1 (fr) * 1985-11-13 1988-09-02 Roussel Uclaf Utilisation de derives de l'ergoline a l'obtention d'un medicament a visee geriatrique
US4798834A (en) * 1987-08-31 1989-01-17 Eli Lilly And Company Optionally substituted (3β-9,10-didehydro-2,3-dihydro ergoline as serotonergic function enhancement
DE3913756A1 (de) * 1989-04-21 1990-10-25 Schering Ag 8(beta)-substituierte ergoline, verfahren zu ihrer herstellung und ihre verwendung
DE10212564B4 (de) * 2002-03-12 2007-04-19 Neurobiotec Gmbh 1-Allyl-ergotalkaloid-Derivate und ihre Verwendung zur Prophylaxe und Therapie von Migräne

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE41533B1 (en) * 1974-03-14 1980-01-30 Sandoz Ltd Thiomethyl ergolene derivatives
US3901894A (en) * 1974-06-06 1975-08-26 Lilly Co Eli 8-thiomethylergolines
US3959288A (en) * 1974-12-13 1976-05-25 Eli Lilly And Company 8-Oxymethylergolines and process therefor
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity

Also Published As

Publication number Publication date
MY8700166A (en) 1987-12-31
PH20385A (en) 1986-12-08
FR2531433A1 (fr) 1984-02-10
FI832789A0 (fi) 1983-08-02
JPS5948480A (ja) 1984-03-19
DK361983A (da) 1984-02-10
BE897473A (fr) 1984-02-06
DE3327705A1 (de) 1984-02-09
IT8322490A0 (it) 1983-08-09
ES524815A0 (es) 1985-02-01
GR78923B (da) 1984-10-02
IL69450A0 (en) 1983-11-30
FI73679C (fi) 1987-11-09
DK361983D0 (da) 1983-08-08
HU187600B (en) 1986-01-28
CA1215972A (en) 1986-12-30
FI832789L (fi) 1984-02-10
FI73679B (fi) 1987-07-31
AU563736B2 (en) 1987-07-23
IT1168961B (it) 1987-05-20
IL69450A (en) 1986-10-31
ATA286383A (de) 1986-10-15
SE8304315L (sv) 1984-02-10
NL8302776A (nl) 1984-03-01
SE8304315D0 (sv) 1983-08-08
NZ205181A (en) 1986-07-11
GB2125041B (en) 1986-04-23
ES8502992A1 (es) 1985-02-01
AT383125B (de) 1987-05-25
AU1767283A (en) 1984-02-16
PT77168A (en) 1983-09-01
GB8321222D0 (en) 1983-09-07
GB2125041A (en) 1984-02-29
PT77168B (en) 1986-03-27
CH649998A5 (de) 1985-06-28
ZA835850B (en) 1985-03-27

Similar Documents

Publication Publication Date Title
FR2535321B1 (fr) Nouveaux derives de l'ethanol, leur preparation et leur utilisation comme fongicides
FR2531083B1 (fr) Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments
FR2501199B1 (fr) Nouveaux polypeptides, leur preparation et leur application comme medicaments
FR2561651B1 (fr) Nouveaux derives de la cyclosporine, leur preparation et leur utilisation comme medicaments
PT76528A (fr) Nouveaux derives d'arene et d'heteroarenecarboxamides et leur utilisation comme medicaments
BE894046A (fr) Alcaloides ergopeptidiques, leur preparation et leur utilisation comme medicaments
BE896993A (fr) FACTEURS 1,2,3,4 et 5 DE TEICHOMYCINE A2, LEUR PREPARATION ET LEUR UTILISATION
FR2531962B1 (fr) Nouveaux derives de la desoxyuridine, leur preparation et leur utilisation comme medicaments
FR2495168B1 (fr) Nouveaux alkylpolyoxyalkylene-carboxylates, leur preparation et leur utilisation comme agents tensio-actifs
FR2560196B1 (fr) Nouvelles 8a-acylaminoergolines, leur preparation et leur utilisation comme medicaments
FR2527608B1 (fr) Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments
BE896590A (fr) Nouveaux azepino-indoles leur preparation et leur utilisation comme medicaments
BE883080A (fr) Nouvelles pyrazinobenzodiazepines, leur preparation et leur application comme medicaments
FR2532308B1 (fr) Nouveaux polypeptides, leur preparation et leur application comme medicaments
FR2528431B1 (fr) Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments
JPS5611926A (en) Manufacture of siliconnreformed polymer having imido group
BE873393A (fr) Nouveaux composes azoiques utilisables comme colorants de dispersion et leur preparation
MA18872A1 (fr) Nouveaux alcaloides de l'ergot de seigle,leur preparation et leur application comme medicaments
FR2519982B1 (fr) Nouveaux derives de l'indoline, leur preparation et leur utilisation comme medicaments
FR2555986B1 (fr) Nouveaux composes phenoliques, leur preparation et leur utilisation comme agents de dispersion et emulsifiants
FR2522663B1 (fr) Nouveaux alcaloides ergopeptidiques, leur preparation et leur utilisation comme medicaments
FR2520741B1 (fr) Nouveaux derives du benzothiophene, leur preparation et leur utilisation comme medicaments
FR2609715B1 (fr) Nouveaux diazepinoindoles, leur preparation et leur utilisation comme medicaments
FR2587333B1 (fr) Nouveaux ethers allyliques bicycliques, leur preparation et leur utilisation comme anti-fongiques et fongicides
PH20385A (en) Ergot alkaloids, compositions containing the same and method of use thereof

Legal Events

Date Code Title Description
ST Notification of lapse